Industry News
Pharmaceutical Industry News

Novo CEO Mike Doustdar—tapped to…
Novo CEO Mike Doustdar—tapped to breathe new life into the Danish drugmaker last year after losing GLP-1 marketing ground to chief rival Eli Lilly—isn’t one to make changes for the sake of change.
It’s time for pharma marketers…
It’s time for pharma marketers to up their ask of AI—not just making better decisions, but building smarter systems that learn from every outcome.
After a 2024 rebuff, AstraZeneca…
After a 2024 rebuff, AstraZeneca and Daiichi Sankyo’s star antibody drug conjugate Enhertu has been deemed cost effective for NHS use in HER2-low advanced breast cancer by England and Wales' drug value assessor.
New phase 3 data show Vera…
New phase 3 data show Vera Therapeutics’ Trutakna successfully stabilizes kidney function in IgA nephropathy patients, mirroring an earlier clinical success from Otsuka’s Voyxact and heating up competition in a rapidly evolving market race.
Cellares is partnering with…
Cellares is partnering with Taiwanese biotech GenomeFrontier Therapeutics to evaluate the integrated contract developer and manufacturer’s cell shuttle platform for use in the production of virus-free CAR-T therapies.
Trialynx takes home the DPHARM…
Trialynx takes home the DPHARM Idol Disrupt award from the 2026 DPHARM conference.
As Amgen advances its bid to join…
As Amgen advances its bid to join the first wave of biosimilars to Bristol Myer Squibb and Ono’s oncology megablockbuster Opdivo, the originator drug’s partners are not taking the challenge lying down.
The health and hygiene…
The health and hygiene conglomerate, known for brands like Lysol and Mucinex, will spend the funds building out an R&D hub at its new headquarters and finalizing the largest of its seven manufacturing sites by
Legend Biotech has found its…
Legend Biotech has found its permanent CEO, poaching 15-year Novartis veteran Ingrid Zhang as the CAR-T specialist eyes its next phase of growth.
As a key player in the automated…
As a key player in the automated cell therapy manufacturing space grapples with a recent setback, another is making waves with a major commercial pact.
The rare disease biotech announced…
The rare disease biotech announced that it would discontinue efforts to develop Voxzogo for children with Noonan syndrome, a genetic growth disorder that can affect height, facial features and the heart.
The Fierce Pharma Marketing Awards…
The Fierce Pharma Marketing Awards celebrated winners across 20 different categories, with GSK, Novartis, argenx and more taking home trophies.
In a deal that allows Sanofi to…
In a deal that allows Sanofi to shed assets wrapped up in mature products, German drugmaker Cheplapharm will take over 20 medicines and three manufacturing sites from Sanofi. In exchange, Sanofi is picking up a
AbbVie has partnered with the PGA…
AbbVie has partnered with the PGA Tour and the 2026 Presidents Cup, teeing up the “Birdies for Brain Health” initiative to funnel cash to six patient advocacy organizations.
The FDA has approved the…
The FDA has approved the industry’s first radioligand equivalent in Curium’s lutetium Lu 177 dotatate injection, Bexlutry, after a court cleared the Boston company of all patent claims brought by Novartis.
Lindsey Vonn knows more than most…
Lindsey Vonn knows more than most about pain. Spending years training as an elite alpine ski racer puts enough pressure on your body, but Vonn’s injuries and her major crash earlier this year that nearly
The Escalating Warnings About A.I., and the Rise of a Deadly New Street Drug
Plus, the man who went to space — and never wanted to go back.
As trial complexity grows, agentic…
As trial complexity grows, agentic AI is emerging as a new model for connecting workflows and accelerating execution.
Shionogi is stepping up promotion…
Shionogi is stepping up promotion of COVID-19 drug Xocova, working with The Bloc on an omnichannel campaign designed to encourage people to contact their healthcare professional after being exposed to the virus.
The injectable monoclonal antibody…
The injectable monoclonal antibody is the first to treat muscle atrophy in patients with SMA, according to the FDA.


